Study S000781

Obesity Management for Kidney TRANSPLANTation: a Vanguard Study for an Innovative Randomized Controlled Trial, Embedded in Routine Care (OK-TRANSPLANT 2)

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT06396416
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE4
Masking: DOUBLE
Status: RECRUITING
Enrollment: 60
Start: 2024-09-26
Primary completion: 2026-09-30
Lead sponsor: Western University, Canada
Conditions: Obesity; Chronic Kidney Disease
Interventions: DRUG:Semaglutide; BEHAVIORAL:Virtual Weight Management Coaching
Results posted: FALSE
Individual participant data sharing: YES

Registered primary outcomes

Feasibility of Recruitment [12 months]

Linked records (1)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

Record	Title	Year	Design	Identifiers	Link basis
R0019953	Obesity management for kidney TRANSPLANTation: protocol for the vanguard phase of an innovative randomised controlled trial, embedded in routine care (OK-TRANSPLANT 2). Clemens KK, BMJ open	2026	Protocol	PMID 42580835 DOI	cites ClinicalTrials.gov:NCT06396416; registry reference DERIVED:42580835